Bronstein, Gewirtz & Grossman, LLC Encourages Cerevel Therapeutics Holdings, Inc. (CERE) Shareholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / February 1, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or "the Company") (NASDAQ:CERE). Investors who purchased Cerevel securities prior to October 11, 2023, and continue to hold to the present, are encouraged to obtain […]